Oncolytic & Unique Viruses
Innovative Solutions for Viral-Based Therapeutics
Oncolytic and other engineered viruses are transforming cancer treatment and gene-modified therapeutics, leveraging the power of selective viral replication to target diseased cells with precision. Advancing these complex biologics requires specialized virotherapy expertise, tightly controlled manufacturing processes, and advanced analytical strategies to ensure consistent potency, purity, and regulatory compliance from development through commercialization.
ReciBioPharm offers end-to-end development and GMP manufacturing for oncolytic and unique viruses. With over 20 years of live virus and bacterial production experience, our facilities are designed to support complex viral therapeutics from early development through commercial production.
Comprehensive Oncolytic Virus Development & Manufacturing
Our virotherapy platform supports a seamless transition from process development to GMP manufacturing.
Oncolytic virus expertise
Recipharm Advanced Bio has extensive experience with a wide range of oncolytic viruses, including:
- Arenavirus
- Adenovirus (Ad)
- Herpes simplex virus (HSV)
- Fowlpox virus (FPV)
- Modified vaccinia Ankara (MVA)
- Newcastle disease virus (NDV)
- Measles virus (MV)
- Vaccinia / modified vaccinia Ankara (MVA)
- Vesicular stomatitis virus (VSV)
We offer egg-based, chick embryo fibroblasts (CEF) and continuous cell line production for these oncolytic viruses, utilizing HEK293/T, A549, VERO, and MRC-5 cell lines.
Process development & optimization
- Unique experience across mammalian cell and egg-based production processes
- Plug-and-play analytical development with a large portfolio of in-house assays
- Defined process characterization to ensure smooth tech transfer and scale-up
GMP manufacturing & scale-up
- 500L drug substance capacity for large-scale virus production
- 30,000 vials per day capacity (2R vial format) for scalable drug product manufacturing
- Direct transfer from process development to GMP—eliminating the need for engineering runs
- Critical equipment aligned across process development and GMP manufacturing, ensuring seamless scale-up
- End-to-end solutions for drug substance and drug product manufacturing under one roof
Our deep expertise in oncolytic virus production and integrated development, manufacturing, and analytical capabilities provides a robust pathway for clinical and commercial success.
Fast Tech Transfer & Rapid Start-Up
Recipharm Advanced Bio’s solution-oriented team ensures a smooth and efficient tech transfer process. Our PM-centered project execution model accelerates project timelines while maintaining quality and compliance.
Key benefits include:
- Rapid product start-up with an optimized material transfer process
- Process alignment across development and GMP manufacturing for efficient scale-up
- Seamless integration with downstream processing for vial filling, lyophilization, and final product manufacturing
We leverage decades of experience in virotherapy manufacturing to reduce risks, minimize delays, and optimize production timelines for your unique virus-based therapy.
Comprehensive Virus & Viral Vector Solutions
Recipharm Advanced Bio offers fully integrated solutions for the development and manufacture of virotherapies. Our expertise in process development, scale-up, and GMP manufacturing ensures a seamless pathway for advancing your viral-based therapies.
Our in-house vector design and process development expertise delivers consistently high-quality final pDNA products
Recipharm Advanced Bio’s high-quality cell and virus banks are developed in multiple expansion formats and sizes to meet GMP and client requirements
Recipharm Advanced Bio has extensive experience providing GMP sterile fill-finish services for customers worldwide
Oncolytic & Unique Virus Resources
Advancing Your Program Together
Your program isn’t just another project—it’s a breakthrough in the making. At Recipharm Advanced Bio, we bring deep scientific expertise, innovative thinking, and a problem-solving mindset to every partnership. Whether scaling a complex process, navigating regulatory pathways, or optimizing for commercial success, we’re here to collaborate, adapt, and deliver with excellence.
Let’s push the boundaries of possibility together and bring transformative therapies to patients faster.